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OBJECTIVES: To evaluate an online freeware calculator that
generates incremental cost effectiveness ratios and quadrant plots
for formulary drug classes. METHODS: Online software was
developed and results were compared with a published pharma-
coeconomic analysis on the cost and effectiveness of several oral
triptan drugs for migraine treatment. The web-based, formulary
cost effectiveness calculator and grapher is freely available
through HDS, www.HealthStrategy.com. The triptan data and
analysis was based on a published article by Ho MJ et al., The
Role of Pharmacoeconomics in Formulary Management: Triptan
Case Study for Migraine, accessible through www.formkit.com/
ptjournal. RESULTS: The HDS calculator runs online through
most computer operating systems with a javascript enabled
browser such as Internet Explorer, Firefox, Opera, or Safari. Up
to seven different drugs in a class can be compared by inputting
the cost and effectiveness per each drug. This Internet tool
outputs tables with incremental cost effectiveness ratios and also
generates graphs such as bar charts and incremental cost effec-
tiveness ratio (ICER) slopes. Respective mean ICERs from the
Ho article versus HDS, with Eletriptan as the central reference,
comparator, were as follows: Rizatriptan:($20.84 vs $21.62),
Zolmitriptan:($24.63 vs $27.50) Almotriptan:($38.60 vs
$45.67), Naratriptan:($62.11 vs $88.50), Sumatriptan:(-$63.52
vs -$62.25 [dominated]), Frovatriptan:($-2.22 vs -$2.20 [domi-
nated]). ICER bar graphs are available in both reports, but HDS
provides ICER quadrant plots, and more clearly presents favor-
able and dominated options. The Ho article includes additional
results with sensitivity analyses. CONCLUSIONS: In the current
HDS version, the user can enter seven therapies in a class for
comparison. The HDS interactive freeware provides very basic
statistical and charting features that may be useful for formulary
cost effectiveness comparisons for drugs in the same class. This
online software has potential beneﬁt as an easily accessibility tool
for students, health professionals, and decision makers.
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